Identification and characterization of a novel de novo mutation (L346V) in the thyroid hormone receptor beta gene in a family with generalized thyroid hormone resistance

in European Journal of Endocrinology
Authors:
E MacchiaIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by E Macchia in
Current site
Google Scholar
PubMed
Close
,
M GurnellIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by M Gurnell in
Current site
Google Scholar
PubMed
Close
,
M AgostiniIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by M Agostini in
Current site
Google Scholar
PubMed
Close
,
G GiorgilliIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by G Giorgilli in
Current site
Google Scholar
PubMed
Close
,
C MarcocciIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by C Marcocci in
Current site
Google Scholar
PubMed
Close
,
TM ValentiIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by TM Valenti in
Current site
Google Scholar
PubMed
Close
,
E MartinoIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by E Martino in
Current site
Google Scholar
PubMed
Close
,
KK ChatterjeeIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by KK Chatterjee in
Current site
Google Scholar
PubMed
Close
, and
A PincheraIstituto di Endocrinologia, Universita di Pisa, Italy.

Search for other papers by A Pinchera in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

We have investigated an Italian family with generalized resistance to thyroid hormone (RTH), consisting of two individuals with elevated serum thyroid hormones (TH) and a non-suppressed TSH, together with unaffected family members, for a mutation in the thyroid hormone receptor beta gene (hTR beta). We have identified a single nucleotide substitution (1321 CTT to GTT) corresponding to a leucine to valine substitution at codon 346 (L346V) in the predicted protein. The index case and her affected child are heterozygous for the receptor defect, with normal sequence in unaffected family members. Furthermore, both parents of the index case were unaffected, suggesting that the mutation had arisen de novo. When expressed in vitro, the L346V mutant receptor showed a marked reduction in its affinity for tri-iodothyronine (T3), impaired ligand-dependent transactivation and potent dominant negative activity. Its functional impairment could not be alleviated, even at supraphysiological concentrations of T3, suggesting that the mutation might interfere with the intrinsic ligand-dependent transactivation function (AF-2) located in the hormone binding domain of hTR beta. Finally, the presence of the L346V mutation in the son of the propositus, who died from complications associated with congenital heart disease, raises the possibility that RTH might have contributed to the pathogenesis or severity of the latter.

 

  • Collapse
  • Expand

     European Society of Endocrinology